Rituximab Reduces Kidney Inflammation in Patients with Lupus

Study Indicates Immunosuppressive Drug Could Help Physicians Manage Lupus Nephritis

Washington, March 3, 2009 — Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that this immunosuppressive agent could improve the health of patients who have few other treatment options and who might otherwise develop end-stage renal disease (ESRD).